Literature DB >> 24711044

High density of CD68+/CD163+ tumour-associated macrophages (M2-TAM) at diagnosis is significantly correlated to unfavorable prognostic factors and to poor clinical outcomes in patients with diffuse large B-cell lymphoma.

Francesco Marchesi1, Mariangela Cirillo2, Antonella Bianchi2, Michela Gately1, Odoardo M Olimpieri1, Elisabetta Cerchiara1, Daniela Renzi1, Alessandra Micera3, Bjorn O Balzamino3, Stefano Bonini4, Andrea Onetti Muda2, Giuseppe Avvisati1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24711044     DOI: 10.1002/hon.2142

Source DB:  PubMed          Journal:  Hematol Oncol        ISSN: 0278-0232            Impact factor:   5.271


× No keyword cloud information.
  38 in total

Review 1.  [Tumor-associated macrophages: Function and differentiation].

Authors:  G Niedobitek; M H Barros; J H Dreyer; F Hauck; D Al-Sheikhyaqoob
Journal:  Pathologe       Date:  2015-09       Impact factor: 1.011

2.  Stromal immune infiltration in HIV-related diffuse large B-cell lymphoma is associated with HIV disease history and patient survival.

Authors:  Chun Chao; Lanfang Xu; Michael J Silverberg; Otoniel Martínez-Maza; Lie-Hong Chen; Brandon Castor; Donald I Abrams; Hongbin D Zha; Reina Haque; Jonathan Said
Journal:  AIDS       Date:  2015-09-24       Impact factor: 4.177

3.  Tumor-associated macrophages in diffuse large B-cell lymphoma.

Authors:  Robert Kridel; Christian Steidl; Randy D Gascoyne
Journal:  Haematologica       Date:  2015-02       Impact factor: 9.941

4.  IL-21 Selectively Protects CD62L+ NKT Cells and Enhances Their Effector Functions for Adoptive Immunotherapy.

Authors:  Ho Ngai; Gengwen Tian; Amy N Courtney; Soodeh B Ravari; Linjie Guo; Bin Liu; Jingling Jin; Elise T Shen; Erica J Di Pierro; Leonid S Metelitsa
Journal:  J Immunol       Date:  2018-08-15       Impact factor: 5.422

5.  A novel lymphoma-associated macrophage interaction signature (LAMIS) provides robust risk prognostication in diffuse large B-cell lymphoma clinical trial cohorts of the DSHNHL.

Authors:  Annette M Staiger; Michael Altenbuchinger; Marita Ziepert; Christian Kohler; Heike Horn; Michael Huttner; Katrin S Hüttl; Gunther Glehr; Wolfram Klapper; Monika Szczepanowski; Julia Richter; Harald Stein; Alfred C Feller; Peter Möller; Martin-Leo Hansmann; Viola Poeschel; Gerhard Held; Markus Loeffler; Norbert Schmitz; Lorenz Trümper; Tobias Pukrop; Andreas Rosenwald; German Ott; Rainer Spang
Journal:  Leukemia       Date:  2019-09-17       Impact factor: 11.528

Review 6.  Immune Dysfunction in Non-Hodgkin Lymphoma: Avenues for New Immunotherapy-Based Strategies.

Authors:  Lorenzo Falchi
Journal:  Curr Hematol Malig Rep       Date:  2017-10       Impact factor: 3.952

7.  B cell lymphoma progression promotes the accumulation of circulating Ly6Clo monocytes with immunosuppressive activity.

Authors:  Sara J McKee; Zewen K Tuong; Takumi Kobayashi; Brianna L Doff; Megan Sf Soon; Michael Nissen; Pui Yeng Lam; Colm Keane; Frank Vari; Davide Moi; Roberta Mazzieri; Graham Leggatt; Maher K Gandhi; Stephen R Mattarollo
Journal:  Oncoimmunology       Date:  2017-12-18       Impact factor: 8.110

8.  Molecular and clinical characterization of CD163 expression via large-scale analysis in glioma.

Authors:  Shasha Liu; Chaoqi Zhang; Nomathamsanqa Resegofetse Maimela; Li Yang; Zhen Zhang; Yu Ping; Lan Huang; Yi Zhang
Journal:  Oncoimmunology       Date:  2019-04-17       Impact factor: 8.110

Review 9.  CAR T-Cell Therapy: The Role of Physical Barriers and Immunosuppression in Lymphoma.

Authors:  Gunilla Enblad; Hannah Karlsson; Angelica S I Loskog
Journal:  Hum Gene Ther       Date:  2015-08       Impact factor: 5.695

10.  Reprogramming Nurse-like Cells with Interferon γ to Interrupt Chronic Lymphocytic Leukemia Cell Survival.

Authors:  Shalini Gautam; Kavin Fatehchand; Saranya Elavazhagan; Brenda F Reader; Li Ren; Xiaokui Mo; John C Byrd; Susheela Tridandapani; Jonathan P Butchar
Journal:  J Biol Chem       Date:  2016-05-13       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.